Is Novavax a good stock to buy now?

Table of Contents

Fundamental Analysis Of NVAX Stock In 2021, Novavax lost $23.44 per share, widening from a per-share loss of $7.27 in 2020. Analysts expected a loss of $13.70 per share in 2021. This year, analysts expect Novavax to become profitable with per-share earnings of $23.73.

Is Novavax a buy Zacks?

Zacks’ proprietary data indicates that Novavax, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the NVAX shares relative to the market in the next few months.

Who owns the most Novavax stock?

The Vanguard Group, Inc.
Top 10 Owners of Novavax Inc

Stockholder	Stake	Shares owned
The Vanguard Group, Inc.	8.79%	6,868,884
BlackRock Fund Advisors	4.64%	3,626,649
SSgA Funds Management, Inc.	3.19%	2,495,542
Susquehanna Financial Group LLLP	1.70%	1,331,118

Will Novavax stock go up tomorrow?

Tomorrow’s movement Prediction of Novavax, Inc. NVAX as on 20 May 2022 looks Bearish……Munafa value: 35 as on 20 Fri May 2022.

Downside target	44.87
Upside target	57.22
Upside target	57.3
Upside target	61.19
Upside target	61.78

Is Novavax publicly traded?

Common Stock (NVAX)

Does Vanguard own Novavax?

2022-02-10 – Vanguard Group Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,897,007 shares of Novavax, Inc. (US:NVAX). This represents 9.12 percent ownership of the company.

Is Nvax being shorted?

Stock – Short Squeeze, Short Sale Volume, Borrow Rates, Fails-To-Deliver….Sign Up for a Forever Free Fintel Account.

Short Interest	shares – source: NASDAQ
Off-Exchange Short Volume Ratio	46.95% – source: FINRA (inc. Dark Pool volume)
Finpedia Article	Novavax